16 July 2025
Pathophysiology | Highly Cited Papers Published in 2023

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
As all of the articles published in Pathophysiology (ISSN: 1873-149X) are of open access format, you have free and unlimited access to the full text of all articles. We invite you to read our most highly cited papers published in 2023, which are listed below.
1. “Pathophysiology of Red Blood Cell Dysfunction in Diabetes and Its Complications”
by Alyssa Williams, Rosi Bissinger, Hala Shamaa, Shivani Patel, Lavern Bourne, Ferruh Artunc and Syed M. Qadri
Pathophysiology 2023, 30(3), 327-345; https://doi.org/10.3390/pathophysiology30030026
Available online: https://www.mdpi.com/1873-149X/30/3/26
2. “Pathophysiology, Management, and Therapeutics in Subarachnoid Hemorrhage and Delayed Cerebral Ischemia: An Overview”
by Henry W. Sanicola, Caleb E. Stewart, Patrick Luther, Kevin Yabut, Bharat Guthikonda, J. Dedrick Jordan and J. Steven Alexander
Pathophysiology 2023, 30(3), 420-442; https://doi.org/10.3390/pathophysiology30030032
Available online: https://www.mdpi.com/1873-149X/30/3/32
3. “Myc beyond Cancer: Regulation of Mammalian Tissue Regeneration”
by Barbara Illi and Sergio Nasi
Pathophysiology 2023, 30(3), 346-365; https://doi.org/10.3390/pathophysiology30030027
Available online: https://www.mdpi.com/1873-149X/30/3/27
4. “Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance”
by Zinab O. Doha and Rosalie C. Sears
Pathophysiology 2023, 30(3), 400-419; https://doi.org/10.3390/pathophysiology30030031
Available online: https://www.mdpi.com/1873-149X/30/3/31
5. “Hormone Replacement Therapy Does Not Eliminate Risk Factors for Joint Complications following Total Joint Arthroplasty: A Matched Cohort Study”
by Lacee K. Collins, Matthew W. Cole, Timothy L. Waters, Michael Iloanya, Patrick A. Massey and William F. Sherman
Pathophysiology 2023, 30(2), 123-135; https://doi.org/10.3390/pathophysiology30020011
Available online: https://www.mdpi.com/1873-149X/30/2/11
We invite you to read and submit relevant papers to the journal Pathophysiology.
Pathophysiology Editorial Office